 condition. The relative
infrequency of PCD with impending tissue loss, the heterogeneity of patients, and the poor results of anticoagulation
alone make it unlikely that large randomized trials will be
performed. Furthermore, the results of conventional anticoagulation are sufficiently dismal that catheter-directed
pharmacologic thrombolysis for impending venous gangrene in the presence of iliofemoral thrombosis is strongly
recommended (Grade 1A).
Although older series